COINOTAG News reports that former President Trump recently criticized the European Union for not presenting a fair trade agreement. While negotiations with Japan show some promise, their position remains notably stringent. Trump also highlighted the imminent implementation of pharmaceutical tariffs, signaling potential shifts in trade dynamics. Market analysts interpret these remarks as primarily centered on tariff-related concerns. However, one expert suggests that tariffs may have diminished impact, given the possibility of extending the tariff suspension deadline beyond July, which the market has already factored in with an average tariff rate near 10%. Businesses continue to operate under the assumption of tariff rates ranging between 10% and 20%. The outlook for global economic growth now largely depends on the realization of Trump’s proposed “beautiful big deal” and anticipated interest rate reductions. Failure to achieve these could trigger a reassessment of market expectations, potentially dampening risk appetite across sectors.